Sales rise 21.88% to Rs 27.91 crore
Net profit of Medicamen Biotech rose 133.04% to Rs 2.68 crore in the quarter ended September 2017 as against Rs 1.15 crore during the previous quarter ended September 2016. Sales rose 21.88% to Rs 27.91 crore in the quarter ended September 2017 as against Rs 22.90 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales27.9122.90 22 OPM %13.3311.88 -PBDT3.891.92 103 PBT3.371.45 132 NP2.681.15 133Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
